Back to feed

11 Days Per Minute: How Explainable AI Saves Heart Patients

Brazil's Neomed pre-screens ECGs and X-rays with explainable machine learning in minutes; where every heart-attack minute carries 11 days of life, it promises physicians speed and transparency.

Imported to Nodesdaily: (UTC+03:00)
Watch on YouTube — Bhba288HpQc
Reading options

Device speech is unavailable in this browser.

Concept lens

Choose a technical term in this view to read its general definition, teaching example and use in the article.

No terms from our glossary were found in this view. The glossary does not cover every term yet.

During a heart attack the clock does not tick, life drains: every minute costs roughly 11 days. On the Google Cloud Tech channel, the host admits dozens of demo apps never saw daylight and asks the real question: who is solving genuine, weighty problems with AI? Across the table sits Bruno, co-founder and product lead of Brazil's health startup Neomed. His team reads diagnostic images and care data with machine learning and lands them in front of physicians within minutes.

The first knot of the conversation is the question doctors whisper: will AI displace the seasoned physician's intuition? The answer is a firm no. The famous Stanford economist's prophecy that no radiologist would remain within two years is recalled, then countered with fact: radiologist hiring has grown. The system does not replace the doctor, it pre-screens ; catching more patients earlier carries the physician into the golden window where disease is still beatable.

The anatomy of catching it early

Picture it: you fracture an elbow skiing, an X-ray is taken. Bone visible, tissue visible, yet the frame hides an abnormality the eye cannot pick. That is where the system nudges: you came for a fracture, but this pattern looks like bone cancer. What a surgery-rooted hospital in Brazil lived through in its first week is the flesh-and-blood version: three consecutive critical cases of atrial fibrillation . Two went to ablation surgery, one received an implantable cardioverter-defibrillator.

Do the numbers hold? Partly. Atrial fibrillation carries a large share of stroke burden, given as 35 percent in the talk. Per the WHO, ischaemic heart disease is the world's top killer; it took 9.1 million lives in 2021, with stroke third behind it. Against the American Heart Association's 10-minute golden standard from ECG to report, the Neomed line promises under 3 minutes. Seven saved minutes times the 11-day coefficient yields over 2,100 gained life-years; that arithmetic rests on field data reported by the company.

False alarm or missed case?

Does seeing more mean more false positives? That is the cost question. The speaker points to the unwritten part of intelligence: the faculty of discernment . AI and doctor see the same frame, yet the doctor knows the before and after, a stretch of the whole film. So the rule runs in reverse: one extra false alarm costs little next to one missed infarction. The physician takes the alert, returns to the raw data, verifies, and only then speaks.

Can a black box be trusted?

The difference between pizza and a heart valve is the price of error. The speaker recalls his earlier stop: at a food-delivery startup a wrong pizza sparks anger, fixable with a free drink. In healthcare a wrong diagnosis cannot be compensated. Hence the team chose auditable machine learning over glittering generative models. The on-screen panel is its showcase: five ECG derivations scored separately, frequency math dropping in automatically, the raw tracing in front of the doctor. Even where the panel reads 100-percent infarction, the last word belongs to the physician reading it.

The load on the generalist's back

In the emergency room a single doctor runs a marathon inside one head: a feverish child, a cardiac ache, an elderly patient fallen in the bath. Each demands normal ranges, age coefficients, sleep and waking differences. No human brain keeps every correlation across ECG derivations fresh on every shift. That is exactly what the system does: it democratizes specialist knowledge into the generalist's pocket. Knowing that a heart carrying an old infarction scar will always print the same pattern belongs to the same package; spotting the pattern is the machine's job, separating scar from fresh crisis is the doctor's.

No giant language model in the kitchen

The technical question gets a candid answer: there is no single giant model behind the curtain. A multi-model architecture approaches each disease with its own technique; a simple first pass labels each frame normal or abnormal, and abnormal ones fan out to specialist models. The stack scales end to end on TensorFlow and Vertex: 150,000 exams a month, each in about 7 seconds. Last year it was 50,000; the target is 500,000. Hospitals with two hundred devices get no install disk, just a cloud link; local health software is so dated that trust is earned through relationships, not version numbers.

Go slow so you can go fast

The startup world's sacred sentence cannot pass this door: moving fast and breaking things is banned in healthcare. Bessemer Venture Partners' (BVP) 2024 health-tech report confirms the picture; while a large slice of capital flows into AI-flavored health plays, sales cycles in the United States measure 12 to 24 months. In Brazil the frame demands even more patience: a four-year negotiation with one of the country's giant insurer-hospital structures. The story includes near-bankruptcy in 2020, Google for Startups credits matching the cash in the bank, and a Google engineer teaching the team to split normal from abnormal.

Leftovers from the lightning round

The closing lightning round is full of consensus-breaking answers. Regulation is no bottleneck but the strict teacher assigning homework; the gap between running an ECG through an unverified language model and a validated system is the patient's life. Wearables, meanwhile, are overrated: per Harvard Health, capturing an ECG with a smartwatch is proof-of-principle work, heart-attack diagnosis wants 12 derivations plus physician reading, while the watch holds only three channels. The good news hides in existing data: ECG-based studies indexed by the NIH on PubMed show aortic-stenosis signals readable from heart electrics, and the race to squeeze echo-grade tables into routine ECGs has begun.

The finale completes the picture: the surgeon is the top candidate for deepest AI entanglement; genomics-based personalized medicine is underrated; and patients trusting an AI second opinion over a doctor's is a bright warning flag, because hallucination costs lives in this field. The call to engineers is plain: unstructured data piles up like mountains, and curious minds are wanted to separate signal from noise.

Visualization: nodesdaily AI

Key moments

  1. Opening: 11 days per heart-attack minute
  2. The failed Stanford prediction and rising radiologist jobs
  3. Bone-cancer pattern in a fracture X-ray
  4. Three critical atrial fibrillation cases in week one
  5. Live demo: the 100-percent infarction panel
  6. 150,000 exams a month in 7 seconds each
  7. Lightning round: regulation, wearables, surgery

AI commentary

"This conversation pulls the AI-in-healthcare debate away from slogans and onto measurable ground. The speaker leans on explainability, speed and trust economics instead of hype; some figures come from the company's own counters, yet the methodological argument stands firm."

AI assessment

The strongest objection is that nearly every success metric comes from the company's own kitchen. Over 2,100 life-years gained, 35,000 strokes prevented, reports in under three minutes: none of these rest on an independently audited clinical study. BVP benchmarks describe the market at large, not Neomed's outcomes. Listeners should keep the gap between striking arithmetic and evidence grade firmly in mind.

The second gap is generalizability. Data flows from contracted hospitals in Brazil; whether the models hold equal sensitivity across different device fleets, demographics and care protocols is unknown. Bias testing, skin-tone or sex-disaggregated performance and prospective randomized validation never come up. Without them, the picture remains a promising field report.

The speaker's seat colors the narrative too. Bruno wears the engineer and the salesperson hats at once; someone who personally narrates 12 to 24 month sales cycles also folds the trust-building story into the sales pitch. That does not make the claims false, but every case should be assumed selected at its shiniest.

The practical takeaway for readers is clear: get existing exams fully read before chasing pricey new data, know that a smartwatch cannot diagnose a heart attack, and always confirm an AI second opinion with your physician. And if you are building a health startup, memorize the lesson: in this sector, going slow is the only way to go fast.

Sources

6 links; no other published story cites them. Stories sharing a link do not confirm each other; a source's origin is not inferred from how often it is cited.

artificial intelligence · health tech · ecg · machine learning · neomed

Follow the topic

Before this story

A short reading order from earlier stories linked to this event by an editor.

Evidence and sources

Review permitted source passages, versions and origins.

KAYNAKLARLA OKU

Bu haberi açalım.

Hesap kontrol ediliyor…